Why the focus on discovery and diagnostic development?
Our emphasis as a pioneering biotechnology discovery and development company has enabled us to leverage our proprietary clinical proteomic processes to begin the development of tools for diagnosis, prognosis, early detection and drug therapies to address the needs in several types of cancers, metabolic syndrome, cardiovascular, and neurodegenerative and neuromuscular diseases such as ALS (Lou Gehrig’s Disease).